Save Comparison | ![]() Pandion Therapeutics Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants. | ![]() ImCheck Therapeutics ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators . | ![]() Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | ![]() Atara Biotherapeutics Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases. | |
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2017 | Founding Date 2013 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ Watertown, US | Locations Marseille, FR HQ | Locations Watertown, US HQ | Locations Cambridge, US HQ Smithfield, US | Locations South San Francisco, US HQ Zug, CH Aurora, US New York, US Thousand Oaks, US |
Employees | Employees 63 | Employees 403% increase | Employees 8010% increase | Employees 17423% increase | Employees 39326% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 842.7 m | Valuation ($) 1.4 b |
Twitter followers | Twitter followers 250 | Twitter followers 423 | Twitter followers 1.8 k | Twitter followers 1.1 k | Twitter followers 1.3 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) 7 | Number of tweets (last 30 days) 12 | Number of tweets (last 30 days) 22 | Number of tweets (last 30 days) 19 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 4.7 | Average likes per tweet (last 30 days) 5 | Average likes per tweet (last 30 days) 7.7 | Average likes per tweet (last 30 days) 3 | Average likes per tweet (last 30 days) 10.6 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 291875 | Alexa Website Rank N/A | Alexa Website Rank 336012 | Alexa Website Rank 339837 | Alexa Website Rank 238554 |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($167.7m) (FY, 2020) | Net income ($291m) (FY, 2019) |
Funding | |||||
Latest funding round | Latest funding round $ 80m (11 months ago) | Latest funding round $ 53.2m (about 1 year ago) | Latest funding round $ 102m (12 months ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 138m | Total funding raised $ 76.1m | Total funding raised $ 197m | Total funding raised $ 245m | Total funding raised $ 61.8m |
ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
View companyKymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View companyRubius is developing a new class of drugs, Red-Cell Therapeutics™.
View companyAtara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.
View company